HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Menasche, P. Articles by Bloch, G. Search for Related Content PubMed PubMed Citation Articles by Menasche, P. Articles by Bloch, G.

European Journal of Cardio-Thoracic Surgery, Vol 8, 207-213, Copyright © 1994 by European Association for Cardio-thoracic Surgery

ARTICLES

Experimental evaluation of Celsior, a new heart preservation solution

P Menasche, JL Termignon, F Pradier, C Grousset, C Mouas, G Alberici, M Weiss, A Piwnica and G Bloch
Department of Cardiovascular Surgery, Hopital Lariboisiere, Paris.

An original heart preservation solution (Celsior) has been developed, the formulation of which has been designed to fulfil two major objectives: (1) to combine the general principles of hypothermic organ preservation with those specific for the myocardium, and (2) to offer the possibility of being used not only as a storage medium but also as a perfusion fluid during initial donor heart arrest, poststorage graft reimplantation and early reperfusion. The major principles addressed by the Celsior formulation include (1) prevention of cell swelling (by mannitol and lactobionate), (2) prevention of by the Celsior formulation include (1) prevention of cell swelling (by mannitol and lactobionate), (2) prevention of oxygen-derived free radical injury (by reduced glutathione, histidine and mannitol), and (3) prevention of contracture by enhancement of energy production (glutamate) and limitation of calcium overload (high magnesium content, slight degree of acidosis). Two experimental preparations were used: The isolated isovolumic buffer-perfused rat heart model and the heterotopic rabbit heart transplantation model. In isolated heart experiments, hearts were arrested with and stored in Celsior for 5 h at 4 degrees C and subsequently reperfused for 1 h. A similar protocol was used in the transplantation experiments except that the total ischemic time was approximately 1 1/2 h longer (corresponding to 6 h of storage followed by the 25 additional minutes of cold ischemia required for graft implantation.(ABSTRACT TRUNCATED AT 250 WORDS)

This article has been cited by other articles:

				D. Pereda, M. Castella, J.-L. Pomar, R. Cartana, M. Josa, C. Barriuso, J. Roman, and J. Mulet Elective cardiac surgery using Celsior or St. Thomas No. 2 solution: a prospective, single-center, randomized pilot study Eur. J. Cardiothorac. Surg., September 1, 2007; 32(3): 501 - 506. [Abstract] [Full Text] [PDF]

				N. Kajihara, S. Morita, Y. Tanoue, N. Boku, M. Eto, T. Nishida, and R. Tominaga The UW solution has greater potential for longer preservation periods than the Celsior solution: comparative study for ventricular and coronary endothelial function after 24-h heart preservation. Eur. J. Cardiothorac. Surg., May 1, 2006; 29(5): 784 - 789. [Abstract] [Full Text] [PDF]

				Q. Yang and G.-W. He Effect of Cardioplegic and Organ Preservation Solutions and Their Components on Coronary Endothelium-Derived Relaxing Factors Ann. Thorac. Surg., August 1, 2005; 80(2): 757 - 767. [Abstract] [Full Text] [PDF]

				J. Ackemann, W. Gross, M. Mory, M. Schaefer, and M.-M. Gebhard Celsior versus custodiol: early postischemic recovery after cardioplegia and ischemia at 5{degrees}C Ann. Thorac. Surg., August 1, 2002; 74(2): 522 - 529. [Abstract] [Full Text] [PDF]

				S. C. Stoica, D. K. Satchithananda, J. Dunning, and S. R. Large Two-decade analysis of cardiac storage for transplantation Eur. J. Cardiothorac. Surg., October 1, 2001; 20(4): 792 - 798. [Abstract] [Full Text] [PDF]

				J. D. Vega, J. L. Ochsner, V. Jeevanandam, D. C. McGiffin, K. R. McCurry, R. M. Mentzer Jr, J. C. Stringham, R. N. Pierson III, O.H. Frazier, A. H. Menkis, et al. A multicenter, randomized, controlled trial of Celsior for flush and hypothermic storage of cardiac allografts Ann. Thorac. Surg., May 1, 2001; 71(5): 1442 - 1447. [Abstract] [Full Text] [PDF]

				E. Kevelaitis, A. Oubenaissa, J. Peynet, C. Mouas, and P. Menasche Preconditioning by Mitochondrial ATP-Sensitive Potassium Channel Openers : An Effective Approach for Improving the Preservation of Heart Transplants Circulation, November 9, 1999; 100(90002): II-345 - 350. [Abstract] [Full Text] [PDF]

				E. Kevelaitis, J. Peynet, C. Mouas, J.-M. Launay, and P. Menasche Opening of Potassium Channels : The Common Cardioprotective Link Between Preconditioning and Natural Hibernation? Circulation, June 15, 1999; 99(23): 3079 - 3085. [Abstract] [Full Text] [PDF]

				T. Wittwer, T. Wahlers, J. F. Cornelius, S. Elki, and A. Haverich Celsior solution for improvement of currently used clinical standards of lung preservation in an ex vivo rat model Eur. J. Cardiothorac. Surg., May 1, 1999; 15(5): 667 - 671. [Abstract] [Full Text] [PDF]

				B. B. NGIMBOUS, F. BOURGEOIS, C. MAS, M. SIMONNEAU, and J.-M. MOALIC Heart transplantation changes the expression of distinct gene families Physiol Genomics, December 21, 2001; 7(2): 115 - 126. [Abstract] [Full Text] [PDF]